Source: Eur Respir J, 55 (3) 1802456; 10.1183/13993003.02456-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Cristina Cigana, Serena Ranucci, Alice Rossi, Ida De Fino, Medede Melessike, Alessandra Bragonzi. Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa. Eur Respir J, 55 (3) 1802456; 10.1183/13993003.02456-2018

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Source: Eur Respir J , 49 (4)  1600851; DOI: 10.1183/13993003.00851-2016 Year: 2017 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Comparison between two protocols of preventing treatment of chronic Pseudomonas aeruginosa (Pa) infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 An experience of moxifloxacin (MOX) use in therapy of nosocomial pneumonia (NP) in patients who hadn‘t risk factors to be infected by Pseudomonas aeruginosa Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus, but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis}, Source: Eur Respir J 2012; 40: 1014-1023 Year: 2012 Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapy Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Source: Eur Respir J 2003; 21: 401-406 Year: 2003 Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia Source: Eur Respir J 2009; 33: 394-400 Year: 2009 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020